Terrell J, Le T, Paul A, Brinton M, Wilson W, Poon G
Nat Commun. 2024; 15(1):5428.
PMID: 38926367
PMC: 11208454.
DOI: 10.1038/s41467-024-49761-5.
Chia L, Kumar P, Maki M, Ravichandran G, Thilagar S
Int J Pept Res Ther. 2022; 29(1):7.
PMID: 36471676
PMC: 9713128.
DOI: 10.1007/s10989-022-10478-y.
Sekaran S, Liew Z, Yam H, Raju C
Diabetol Metab Syndr. 2022; 14(1):101.
PMID: 35864519
PMC: 9301891.
DOI: 10.1186/s13098-022-00870-5.
Recalde-Reyes D, Rodriguez-Salazar C, Castano-Osorio J, Giraldo M
Peptides. 2022; 153:170797.
PMID: 35378215
PMC: 10807690.
DOI: 10.1016/j.peptides.2022.170797.
Hyatt J, Prevost S, Devos J, Mycroft-West C, Skidmore M, Winter A
Pathogens. 2020; 9(11).
PMID: 33187224
PMC: 7697694.
DOI: 10.3390/pathogens9110935.
Molecular characteristics and replication mechanism of dengue, zika and chikungunya arboviruses, and their treatments with natural extracts from plants: An updated review.
Rodriguez A, Munoz A, Segura N, Rangel H, Bello F
EXCLI J. 2019; 18:988-1006.
PMID: 31762724
PMC: 6868920.
DOI: 10.17179/excli2019-1825.
Folding of the Ig-Like Domain of the Dengue Virus Envelope Protein Analyzed by High-Hydrostatic-Pressure NMR at a Residue-Level Resolution.
Saotome T, Doret M, Kulkarni M, Yang Y, Barthe P, Kuroda Y
Biomolecules. 2019; 9(8).
PMID: 31357538
PMC: 6723665.
DOI: 10.3390/biom9080309.
The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study.
Auerswald H, Klepsch L, Schreiber S, Hulsemann J, Franzke K, Kann S
Viruses. 2019; 11(4).
PMID: 30934772
PMC: 6521013.
DOI: 10.3390/v11040304.
Dynamics and binding interactions of peptide inhibitors of dengue virus entry.
Isa D, Chin S, Chong W, M Zain S, Rahman N, Lee V
J Biol Phys. 2019; 45(1):63-76.
PMID: 30680580
PMC: 6408556.
DOI: 10.1007/s10867-018-9515-6.
Peptides as Therapeutic Agents for Dengue Virus.
Chew M, Poh K, Poh C
Int J Med Sci. 2017; 14(13):1342-1359.
PMID: 29200948
PMC: 5707751.
DOI: 10.7150/ijms.21875.
Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein.
Moraes A, Simonelli L, Pedotti M, Almeida F, Varani L, Valente A
J Virol. 2015; 90(4):1802-11.
PMID: 26637461
PMC: 4733983.
DOI: 10.1128/JVI.02314-15.
Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III.
Ji G, Deng Y, Yu X, Jiang T, Wang H, Shi X
PLoS One. 2015; 10(10):e0139741.
PMID: 26430770
PMC: 4592203.
DOI: 10.1371/journal.pone.0139741.
Thioaptamers targeting dengue virus type-2 envelope protein domain III.
Gandham S, Volk D, Lokesh G, Neerathilingam M, Gorenstein D
Biochem Biophys Res Commun. 2014; 453(3):309-15.
PMID: 25261724
PMC: 4272640.
DOI: 10.1016/j.bbrc.2014.09.053.
Progress in the identification of dengue virus entry/fusion inhibitors.
de la Guardia C, Lleonart R
Biomed Res Int. 2014; 2014:825039.
PMID: 25157370
PMC: 4135166.
DOI: 10.1155/2014/825039.
Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys.
Lin H, Lee H, Li X, Tsai M, Hsiao H, Peng J
PLoS One. 2014; 9(6):e100130.
PMID: 24959738
PMC: 4069063.
DOI: 10.1371/journal.pone.0100130.
Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses.
Maillard R, Liu T, Beasley D, Barrett A, Hilser V, Lee J
J Am Chem Soc. 2014; 136(29):10315-24.
PMID: 24950171
PMC: 4111217.
DOI: 10.1021/ja503318x.
Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
Zidane N, Dussart P, Bremand L, Bedouelle H
BMC Infect Dis. 2013; 13:302.
PMID: 23815496
PMC: 3701519.
DOI: 10.1186/1471-2334-13-302.
Rational engineering of a human anti-dengue antibody through experimentally validated computational docking.
Simonelli L, Pedotti M, Beltramello M, Livoti E, Calzolai L, Sallusto F
PLoS One. 2013; 8(2):e55561.
PMID: 23405171
PMC: 3566030.
DOI: 10.1371/journal.pone.0055561.
Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.
Bowen D, Lewis J, Lu W, Schein C
Vaccine. 2012; 30(42):6081-7.
PMID: 22863657
PMC: 3439202.
DOI: 10.1016/j.vaccine.2012.07.042.
An in-depth analysis of original antigenic sin in dengue virus infection.
Midgley C, Bajwa-Joseph M, Vasanawathana S, Limpitikul W, Wills B, Flanagan A
J Virol. 2010; 85(1):410-21.
PMID: 20980526
PMC: 3014204.
DOI: 10.1128/JVI.01826-10.